FDA revises guidance on electronic systems and signatures in clinical trials
Regulatory NewsFerdous Al-Faruque
North AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsFerdous Al-FaruqueNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy